Author:
Zhou Hongyu,Mao Haixia,Dong Di,Fang Mengjie,Gu Dongsheng,Liu Xueling,Xu Min,Yang Shudong,Zou Jian,Yin Ruohan,Zheng Hairong,Tian Jie,Pan Changjie,Fang Xiangming
Funder
Beijing Natural Science Foundation
Wuxi Medical Innovation Team Program
Youth Innovation Promotion Association CAS
National Key R&D Program of China
National Natural Science Foundation of China
Beijing Municipal Science & Technology Commission
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Bhatt JR, Finelli A. Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol. 2014;11:517–25.
2. Störkel S, Eble JN, Adlakha MD, et al. Classification of renal cell carcinoma. Cancer. 1997;80:987.
3. Rabjerg M. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Dan Med J. 2017;64:B5339.
4. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Histopathology. 2016;46:93–105.
5. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Urol. 2006;175:2763–71.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献